Viva Biotech Holdings
HKEX:1873.HK
0.61 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,013.394 | 1,142.184 | 1,270.884 | 1,108.747 | 1,077.632 | 1,026.451 | 499.401 | 197.557 | 180.716 | 142.341 | 132.651 | 77.382 | 52.508 | 37.061 | 37.061 | 37.061 | 24.123 | 24.123 | 24.123 |
| Cost of Revenue
| 680.93 | 736.216 | 800.177 | 763.775 | 742.926 | 710.176 | 294.653 | 97.439 | 96.734 | 70.45 | 69.481 | 35.095 | 26.144 | 15.514 | 15.514 | 15.514 | 10.587 | 10.587 | 10.587 |
| Gross Profit
| 332.464 | 405.968 | 470.707 | 344.972 | 334.706 | 316.275 | 204.748 | 100.118 | 83.982 | 71.891 | 63.17 | 42.287 | 26.364 | 21.547 | 21.547 | 21.547 | 13.536 | 13.536 | 13.536 |
| Gross Profit Ratio
| 0.328 | 0.355 | 0.37 | 0.311 | 0.311 | 0.308 | 0.41 | 0.507 | 0.465 | 0.505 | 0.476 | 0.546 | 0.502 | 0.581 | 0.581 | 0.581 | 0.561 | 0.561 | 0.561 |
| Reseach & Development Expenses
| 51.267 | 76.7 | 94.918 | 40.917 | 54.906 | 37.476 | 43.717 | 22.324 | 29.338 | 15.616 | 14.128 | 11.123 | 6.313 | 4.313 | 4.313 | 4.313 | 4.199 | 4.199 | 4.199 |
| General & Administrative Expenses
| 145.713 | 131.396 | 131.15 | 142.499 | 125.666 | 100.045 | 74.491 | 35.672 | 30.39 | 20.825 | 15.417 | 10.159 | 12.463 | 3.807 | 3.807 | 3.807 | 3.207 | 3.207 | 3.207 |
| Selling & Marketing Expenses
| 60.107 | 72.44 | 74.897 | 55.907 | 59.258 | 34.716 | 11.144 | 1.951 | 1.734 | 1.837 | 1.778 | 2.147 | 0.981 | 0.504 | 0.504 | 0.504 | 0.348 | 0.348 | 0.348 |
| SG&A
| 213.946 | 203.836 | 212.089 | 198.406 | 186.588 | 135.11 | 84.259 | 38.999 | 30.59 | 24.196 | 17.326 | 12.288 | 13.444 | 4.311 | 4.311 | 4.311 | 3.555 | 3.555 | 3.555 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.953 | -1.435 | -1.435 | -1.435 | -1.486 | -1.486 | -1.486 |
| Operating Expenses
| 350.602 | 294.576 | 781.516 | 330.26 | 32.452 | 114.295 | 23.884 | 591.768 | 131.085 | 18.858 | 17.728 | 17.828 | 18.804 | 7.19 | 7.19 | 7.19 | 6.267 | 6.267 | 6.267 |
| Operating Income
| 67.807 | 124.876 | 165.196 | 100.784 | 93.101 | 143.8 | 74.177 | 38.361 | 22.242 | 32.079 | 31.716 | 18.876 | 26.605 | 21.916 | 21.916 | 21.916 | 7.156 | 7.156 | 7.156 |
| Operating Income Ratio
| 0.067 | 0.109 | 0.13 | 0.091 | 0.086 | 0.14 | 0.149 | 0.194 | 0.123 | 0.225 | 0.239 | 0.244 | 0.507 | 0.591 | 0.591 | 0.591 | 0.297 | 0.297 | 0.297 |
| Total Other Income Expenses Net
| -160.512 | -88.124 | -560.887 | -164.258 | 132.546 | -21.746 | 92.006 | -560.754 | 199.527 | 27.077 | 14.464 | 40.805 | -0.139 | -0.213 | -0.213 | -0.213 | -0.051 | -0.051 | -0.051 |
| Income Before Tax
| -92.705 | 36.752 | -395.691 | -63.474 | 225.647 | 122.054 | 166.183 | -522.393 | 221.769 | 59.156 | 46.18 | 59.681 | 26.465 | 21.703 | 21.703 | 21.703 | 7.105 | 7.105 | 7.105 |
| Income Before Tax Ratio
| -0.091 | 0.032 | -0.311 | -0.057 | 0.209 | 0.119 | 0.333 | -2.644 | 1.227 | 0.416 | 0.348 | 0.771 | 0.504 | 0.586 | 0.586 | 0.586 | 0.295 | 0.295 | 0.295 |
| Income Tax Expense
| 20.744 | 23.093 | 23.309 | 21.746 | 20.889 | 26.252 | 14.781 | 7.879 | 2.393 | 12.66 | 6.436 | 8.875 | 3.828 | 2.638 | 2.638 | 2.638 | 0.987 | 0.987 | 0.987 |
| Net Income
| -117.126 | 1.013 | -437.274 | -91.201 | 202.526 | 85.02 | 143.392 | -530.272 | 219.376 | 46.496 | 39.744 | 50.806 | 22.638 | 19.065 | 19.065 | 19.065 | 6.118 | 6.118 | 6.118 |
| Net Income Ratio
| -0.116 | 0.001 | -0.344 | -0.082 | 0.188 | 0.083 | 0.287 | -2.684 | 1.214 | 0.327 | 0.3 | 0.657 | 0.431 | 0.514 | 0.514 | 0.514 | 0.254 | 0.254 | 0.254 |
| EPS
| -0.14 | 0.001 | -0.23 | -0.05 | 0.043 | 0.04 | 0.082 | -0.38 | 0.14 | 0.03 | 0.037 | 0.04 | 0.015 | 0.013 | 0.013 | 0.013 | 0.004 | 0.004 | 0.004 |
| EPS Diluted
| -0.055 | 0.001 | -0.23 | -0.046 | 0.1 | 0.044 | 0.083 | -0.38 | 0.13 | 0.035 | 0.033 | 0.043 | 0.015 | 0.013 | 0.013 | 0.013 | 0.004 | 0.004 | 0.004 |
| EBITDA
| 162.881 | 228.131 | 252.075 | 184.279 | 162.345 | 207.594 | 113.588 | 50.76 | 32.213 | 38.571 | 37.624 | 22.516 | 28.992 | 23.291 | 23.291 | 23.291 | 8.101 | 8.101 | 8.101 |
| EBITDA Ratio
| 0.161 | 0.2 | 0.198 | 0.166 | 0.151 | 0.202 | 0.227 | 0.257 | 0.178 | 0.271 | 0.284 | 0.291 | 0.552 | 0.628 | 0.628 | 0.628 | 0.336 | 0.336 | 0.336 |